InvestorsHub Logo
Followers 4053
Posts 151215
Boards Moderated 4
Alias Born 08/05/2009

Re: subslover post# 31

Monday, 01/09/2023 8:42:59 AM

Monday, January 09, 2023 8:42:59 AM

Post# of 85
On January 9, 2023, the Company issued a press release providing a
corporate update that included updates on its clinical programs and
an estimate that its cash, cash equivalents and investments as of
December 31, 2022 were approximately $79 million. This amount is
unaudited and preliminary and is subject to completion of financial
closing procedures. Additional information and disclosure would be
required for a more complete understanding of the Company’s
financial position and results of operations as of December 31,
2022.

https://ih.advfn.com/stock-market/NASDAQ/spruce-biosciences-SPRB/stock-news/89937088/spruce-biosciences-provides-clinical-program-updat
Bullish
Bullish

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SPRB News